What We're Reading: Page 107
Industry reads hand-picked by our editors
Oct 28, 2022
-
STAT
Death of patient in closely watched Alzheimer’s trial raises concern about risk for some groups
-
Science
‘Mirror-image’ protein factories could one day make durable drugs the body can’t break down
-
Wired
America’s Adderall Shortage Could Kill People
-
Reuters
China rolls out first inhalable COVID vaccine
Oct 27, 2022
Oct 26, 2022
Oct 25, 2022
-
NPR
Children’s hospitals grapple with a nationwide surge in RSV infections
-
Reuters
AstraZeneca drug fails one main goal in study of chronic immune disease
-
Science
Merck locates frozen batch of undisclosed Ebola vaccine, will donate for testing in Uganda’s outbreak
-
Literary Hub
How Humans Came To Discover the Unseen World of Cells
Oct 24, 2022
-
Reuters
U.S. is talking to companies about drug price negotiations
-
The Wall Street Journal
Deadly Fungi Are Infecting More Americans
-
Bloomberg
Popular Antibiotic Amoxicillin in Short Supply in US
-
FiercePharma
Ex-Genentech staffers sentenced in trade secrets case
Oct 21, 2022
Oct 20, 2022
-
The Wall Street Journal
Drugmakers Look to Limit Medicare’s New Power to Negotiate Lower Drug Prices
-
Bloomberg
Novartis Allows Generic Leukemia Drug Production in Seven Nations
-
FiercePharma
J&J is letting go of 64 staffers in Manhattan
-
Reuters
Falling demand for COVID boosters puts price hikes on the table
Previous
